Peripheral IV Access for Chemo Better Than Central Lines in Testicular Cancer?
Patients with testicular cancer had fewer venous access-related complications and overall thrombotic events when first-line chemotherapy was delivered via peripheral intravenous access compared with central venous access devices (CVADs), a retrospective study suggested. Among 154 patients, those in the CVAD group compared with the peripheral IV group experienced more venous access-related complications (52.2% vs 24.2%) […]
COVID-19 Tied to High Risk of Thrombotic Events
COVID-19 was associated with a greater risk for a host of thrombotic events in the months following a patient’s infection, a large study in Sweden found. Among over 1 million people who tested positive for COVID-19 in the past month, risk for a first pulmonary embolism was 33 times higher compared with a matched control […]